Description
PLUVICTO RADIOPHARM
First action · last action
2024-07-02 · 2025-04-08
Transactions
3
First transaction's obligation
$662,182
Base + all options value (sum of deltas)
$714,171
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79719D0169
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-07-02+$662,182= $662,182
- Mod P000012024-10-30+$85,745= $747,927
- Mod P000022025-04-08-$33,756= $714,171
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-07-02 | +$662,182 | $662,182 | PLUVICTO RADIOPHARM |
| Mod P00001· FUNDING ONLY ACTION | 2024-10-30 | +$85,745 | $747,927 | PLUVICTO RADIOPHARM |
| Mod P00002· CLOSE OUT | 2025-04-08 | −$33,756 | $714,171 | PLUVICTO RADIOPHARM |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JNM4NBNHFE66)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0132 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $1,200,000 | FY2026 |
| 36C26026N0121 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $996,874 | FY2026 |
| 36C24926N0263 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $823,062 | FY2026 |
| 36C25525N0282 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $166,146 | FY2025 |
| 36C25525N0176 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $1,362,395 | FY2025 |
| 36C25225F0044 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $631,354 | FY2025 |
Other recipients under 6505 from 252-NETWORK CONTRACT OFFICE 12 (36C252) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25226N0551 | AMERICAN NATIONAL RED CROSS, THE | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $2,100 | FY2026 |
| 36C25226N0550 | AMERICAN NATIONAL RED CROSS, THE | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $2,500 | FY2026 |
| 36C25226N0549 | AMERICAN NATIONAL RED CROSS, THE | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $170 | FY2026 |
| 36C25226N0548 | AMERICAN NATIONAL RED CROSS, THE | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $10,000 | FY2026 |
| 36C25226N0450 | BOSTON SCIENTIFIC CORP | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $607,804 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25224F0184_3600_36F79719D0169_3600 · retrieved 2026-09-26.